Procter & Gamble Company (0NOF)

London


	Symbol		Exchange		Currency
	PG		NYSE		USD	Real-time
	0NOF		London		USD	Real-time
	PG		CBOE Canada		CAD	Real-time
	PG		Mexico		MXN	Delayed
	1PG		Milan		EUR	Real-time
	PG		TradeGate		EUR	Delayed
	PG		Xetra		EUR	Delayed
	PG		Frankfurt		EUR	Delayed
	PGm		Buenos Aires		ARS	Delayed
	PGCO34		B3		BRL	Delayed
	PG		Vienna		EUR	Real-time
	PG		Ukraine		UAH	Delayed
	PG		Lima		USD	Delayed

Currency in USD

Disclaimer

169.52

+0.72(+0.43%)

Real-time Data15:48:34

Fair Value

Day's Range

169.00

169.75

52 wk Range

142.50

177.20

0NOF Income Statement

Featured here, the Income Statement (earnings report) for Procter & Gamble Company, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

30/06

2016

30/06

2017

30/06

2018

30/06

2019

30/06

2020

30/06

2021

30/06

2022

30/06

2023

30/06

2024

30/06

Total Revenues

70,950

76,118

80,187

82,006

84,039

Total Revenues Growth

+4.83%

+7.28%

+5.35%

+2.27%

+2.48%

Cost Of Revenues

35,250

37,108

42,157

42,600

40,600

Gross Profit

35,700

39,010

38,030

39,406

43,439

Gross Profit Growth

+8.46%

+9.27%

-2.51%

+3.62%

+10.23%

Gross Profit Margin %

50.32%

51.25%

47.43%

48.05%

51.69%

Other Operating Expenses, Total

19,597

20,527

19,585

20,349

22,491

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+4.75%	+4.75%	-4.59%	+3.9%	+10.53%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	19,597	20,527	19,585	20,349	22,491
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

16,103

18,483

18,445

19,057

20,948

Operating Income Growth

+13.35%

+14.78%

-0.21%

+3.32%

+9.92%

EBIT Margin %

22.7%

24.28%

23%

23.24%

24.93%

Net Interest Expenses

-310

-457

-388

-449

-452

Net Interest Expenses Growth

-7.27%

-47.42%

+15.1%

-15.72%

-0.67%

Interest Expense, Total

-465

-502

-439

-756

-925

Interest And Investment Income

155

45

51

307

473

Other Non Operating Expenses, Total

54

-392

-57

83

271

EBT, Excl. Unusual Items

15,847

17,634

18,000

18,691

20,767

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-13

-19

-5

-9

-1,348

EBT, Incl. Unusual Items

15,834

17,615

17,995

18,353

18,761

EBT, Incl. Unusual Items Growth

+160.9%

+11.25%

+2.16%

+1.99%

+2.22%

EBT, Incl. Unusual Items Margin

22.32%

23.14%

22.44%

22.38%

22.32%

Income Tax Expense

2,731

3,263

3,202

3,615

3,787

Net Income to Company

13,103

14,352

14,793

14,738

14,974

Minority Interest

-76

-46

-51

-85

-95

Net Income

13,027

14,306

14,742

14,653

14,879

Net Income Growth

+234.28%

+9.82%

+3.05%

-0.6%

+1.54%

Net Income Margin %

18.36%

18.79%

18.38%

17.87%

17.7%

Preferred Dividend and Other Adjustments

263

271

281

282

284

Net Income to Common Excl. Extra Items

12,764

14,035

14,461

14,371

14,595

Basic EPS - Continuing Operations

5.13

5.69

6

6.07

6.18

Basic EPS - Continuing Operations Growth

+253.57%

+10.91%

+5.41%

+1.14%

+1.91%

Diluted EPS - Continuing Operations

4.96

5.5

5.81

5.9

6.02

Diluted EPS - Continuing Operations Growth

+246.93%

+10.87%

+5.56%

+1.61%

+2.04%

Basic Weighted Average Shares Outstanding

2,487.1

2,465.8

2,410.3

2,368.2

2,360.1

Diluted Weighted Average Shares Outstanding

2,625.8

2,601

2,539.1

2,483.9

2,471.9

Dividend Per Share

3.03

3.24

3.52

3.68

3.83

Dividend Per Share Growth

+4.52%

+7.05%

+8.66%

+4.48%

+4.02%

EBITDA

19,116

21,218

21,252

21,771

23,844

EBITDA Growth

+12.24%

+11%

+0.16%

+2.44%

+9.52%

EBITDA Margin %